CHARLES WYKOFF to Vascular Endothelial Growth Factor C
This is a "connection" page, showing publications CHARLES WYKOFF has written about Vascular Endothelial Growth Factor C.
Connection Strength
0.057
-
A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration. Ophthalmology. 2023 06; 130(6):588-597.
Score: 0.057
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.